Work

Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

Year: 2004

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/b:drug.0000011794.21608.59

Authors: G. Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, Joel Sheinfeld, Dean Bajorin, Jacqueline Vuky, Stephanie Marion, Madhu Mazumdar, George J. Bosl, Robert J. Motzer

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2275201606, CLINICAL TRIALS AND MENTORING IN ONCOLOGY RESEARCH, G5182571551, Investigational Cancer Therapeutics Training Program (ICTTP)

OpenAlex ID: W2014445594

FWCI: 1.267

Cites: 8

Cited by: 14

Related to: 10